Dermacy Healthcare Profile
Key Indicators
- Authorised Capital ₹ 2.60 Cr
- Paid Up Capital ₹ 1.43 Cr
- Company Age 13 Year, 3 Months
- Last Filing with ROC 31 Mar 2021
- Satisfied Charges ₹ 5.00 M
- Revenue Growth -78.69%
- Profit Growth 105.47%
- Ebitda 94.65%
- Net Worth 252.52%
- Total Assets -91.73%
About Dermacy Healthcare
Dermacy Healthcare Private Limited (DHPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 October 2011 and has a history of 13 years and three months. Its registered office is in Delhi, India.
The Company is engaged in the Internet Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 2.60 Cr and a paid-up capital of Rs 1.43 Cr.
The company has closed loans amounting to ₹5.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Aditya Malhotra and Ankit Khurana serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U52300DL2011PTC226595
- Company No.
226595
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Oct 2011
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Dermacy Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aditya Malhotra  | Director | 15-Dec-2015 | Current |
| Ankit Khurana | Director | 20-Oct-2011 | Current |
Financial Performance of Dermacy Healthcare.
Dermacy Healthcare Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 78.69% decrease. The company also saw a substantial improvement in profitability, with a 105.47% increase in profit. The company's net worth Soared by an impressive increase of 252.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dermacy Healthcare?
In 2021, Dermacy Healthcare had a promoter holding of 78.09% and a public holding of 21.91%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Symbiotic Sciences Private LimitedAditya Malhotra is a mutual person
Arm Biotechnologies Private LimitedAditya Malhotra is a mutual person
Charges (Loans)
₹0
₹0.50 Cr
Charges Breakdown by Lending Institutions
- Others : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Feb 2019 | Others | ₹5.00 M | Satisfied |
How Many Employees Work at Dermacy Healthcare?
Dermacy Healthcare has a workforce of 5 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dermacy Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dermacy Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
